John Keith Ramage
University of Winchester · 328 works · 12,857 citations · h-index 54
Top works
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
- Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
- Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation
- Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
- PTU-133 Goblet Cell Carcinoma of the Appendix: Acute vs Chronic Presentations
- Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach
- Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
- ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
- Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
- Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
- RANITIDINE 150 mg TWICE DAILY VS 300 mg NIGHTLY IN TREATMENT OF DUODENAL ULCERS
- Ribavirin therapy for hepatitis C infection following liver transplantation
- Effect of immunologic reactions on rat intestinal epithelium
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
- Gastrinoma (Duodenal and Pancreatic)
- ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.